Form 4 for MRK Merck & Co.
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-04 · accession 0001127602-23-014751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-05 | 2023-05-04 | MRK | Klobuchar Michael A | EVP - Chief Strategy Off | M - OptEx | $118.22 | +885 | 19.5K | +5% | +$104.6K |
| D | 2023-05-05 | 2023-05-04 | MRK | Klobuchar Michael A | EVP - Chief Strategy Off | F - Tax | $118.22 | -436 | 19.0K | -2% | -$51.5K |
| D | 2023-05-05 | 2023-05-04 | MRK | Klobuchar Michael A | EVP - Chief Strategy Off | M - OptEx | $0.00 | -885 | 887 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | M | A | 885 | $118.22 | 19,476 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-04 | F | D | 436 | $118.22 | 19,040 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-05-04 | M | D | 885 | $0.00 | 887 | D | — · 2022-05-04 to 2024-05-04 | 885 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |